ClearPoint Neuro to Present at Upcoming Investor Conferences

Rhea-AI Summary

ClearPoint Neuro, Inc. (Nasdaq: CLPT) announced its participation in upcoming investor conferences. Management will present at the 2022 Stifel Healthcare Conference on November 15, 2022, at 10:55 a.m. ET in New York, and at the 34th Annual Piper Sandler Healthcare Conference on November 29, 2022, at 11:50 a.m. ET, also in New York. ClearPoint Neuro focuses on enabling therapies for complex neurological disorders, with its navigation system having FDA clearance and operational at over 60 sites globally.

SOLANA BEACH, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, announced today that its management will present at the following investor conferences:

• 2022 Stifel Healthcare Conference
  Presenting on Tuesday, November 15, 2022 at 10:55 a.m. Eastern Time in New York, NY.

• 34^th Annual Piper Sandler Healthcare Conference
  Presenting on Tuesday, November 29, 2022 at 11:50 a.m. Eastern Time in New York, NY.

About ClearPoint Neuro

ClearPoint Neuro’s mission is to improve and restore quality of life to patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy. Applications of the Company’s current product portfolio include deep brain stimulation, laser ablation, biopsy, neuro-aspiration, and delivery of drugs, biologics, and gene therapy to the brain. The ClearPoint Neuro Navigation System has FDA clearance, is CE-marked, and is installed in over 60 active sites in the United States, Canada, and Europe. ClearPoint Neuro is partnered with approximately 50 pharmaceutical and biotech companies, academic institutions, and contract research organizations providing solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide. To date, more than 5,000 cases have been performed and supported by the Company’s field-based clinical specialist team, which offers support and services to our customers and partners worldwide. For more information, please visit www.clearpointneuro.com. 

FAQ

What are the dates for ClearPoint Neuro's presentations at investor conferences in November 2022?

ClearPoint Neuro will present at the Stifel Healthcare Conference on November 15, 2022, and at the Piper Sandler Healthcare Conference on November 29, 2022.

Where will ClearPoint Neuro present in November 2022?

Both presentations by ClearPoint Neuro will take place in New York, NY.

What is ClearPoint Neuro's mission?

ClearPoint Neuro aims to improve quality of life for patients by enabling therapies for complex neurological disorders.

How many active sites does ClearPoint Neuro have for its navigation system?

ClearPoint Neuro's navigation system is installed in over 60 active sites across the United States, Canada, and Europe.

What types of therapies does ClearPoint Neuro support?

ClearPoint Neuro supports therapies including deep brain stimulation, laser ablation, biopsy, neuro-aspiration, and drug delivery to the brain.

What is the stock symbol for ClearPoint Neuro?

The stock symbol for ClearPoint Neuro is CLPT.